Clinical Trial Update: Glumetinib Combined With Toripalimab in the Treatment of Relapsed or Metastatic Non-small Cell Lung Cancer. [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial exploring glumetinib with toripalimab for relapsed or metastatic non-small cell lung cancer in phase 1/2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Or Metastatic Non-small Cell Lung Cancer

Drugs mentioned

• Glumetinib
• Toripalimab (Toripalimab)

Snippet

Sponsor: Shanghai Junshi Bioscience Co., Ltd. | Conditions: Relapsed or Metastatic Non-small Cell Lung Cancer | Phase 1, Phase 2 | Status: UNKNOWN